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Магнетната резонанца е основен дијагностички  метод  за селекција на пациенти со докажан рек-
тален карцином кои имаат потреба од  предоперативна хеморадиотерапија со цел намалување на 
стадиумот на болеста. Целта на овој труд беше да се направи евалуација на ефектите од хемора-
диотерапијата во напреднат стадиум на ректален карцином, со споредба на МР прегледот пред и 
по третманот. Материјал и методи: Проспективно, беа евалуирани  МР наоди  на 15 пациенти со 
ректален карцином потврден на колоноскопија. Кај сите пациенти беше направен предоперати-
вен неадјувантен третман и беше направи контролен МР преглед по 6 до 8 недели. МР прегледот 
беше направен на 1.5T магнет, во пулс секвенци: сагитален T2WI, аксијален T1WI, T2WI и DWI. 
На МР беше утврден Т стадиумот, нодалниот стадиум, присуство на екстрамурална васкуларна 
инвазија (ЕМВИ), локализација на тумор во ректумот (низок, среден, висок ректум, ректосигмои-
ден спој). Компјутерска томографија беше направена кај сите пациенти за утврдување на далечни 
метастази. Резултати: Од 15 пациенти, 12 беа мажи  (66,7%), а 3 (33,3%) беа жени, на возраст од 50 до 
80 години. Локализација на ректален карцином: кај 6 пациенти во низок ректум, кај 6 пациенти во 
среден ректум и кај 3 пациенти на ректосигмоиден спој. На првичниот МР преглед, 7 (46,6%) паци-
енти беа во Т3 стадиум, 8 (53,3%)  во  Т4 стадиум. Споредбата на резултатите од МР прегледот пред 
и по хеморадиотерапијата покажа намалување на стадиумот во 5 (33,3%) од Т4 во Т3 фаза. Кај 11 
пациенти (73,7%), ЕМВИ по терапијата стана негативна со статистички значајна разлика пред и по 
хеморадиотерапијата. Сите пациенти пред терапијата имаа различен број на метастатски лимфни 
јазли во мезоректум, со намалување на бројот во сите случаи по терапијата, а двајца пациенти беа 
без метастатски лимфни јазли. Заклучок: МР има значајна вредност во проценката на ефектите од 
хеморадиотерапијата. Ова е важно за оперативно планирање со цел да се избегне широка ресек-
ција со хируршки техники кои го зачувуваат аналниот сфинктер.
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MRI is a basic tool in patient selection for preoperative neoadjuvant treatment of rectal carcinoma, 
with assessment of stage reduction. The aim of the paper was to evaluate chemoradiotherapy effects in 
advanced stage rectal carcinoma by comparison of MRI findings before and after chemoradiotherapy. 
Material and methods: Prospectively, MRI findings of 15 patients with rectal carcinoma confirmed at 
colonoscopy, were evaluated. In all patients preoperative neoadjuvant treatment was done and MRI 
restaging was performed after 6 to 8 weeks. MRI standard protocol was done on 1.5T machine, sagital 
T2WI, axial T1WI, T2WI and DWI. On MRI was assessed tumor and nodal stage, presence of extra-
mural vascular invasion (EMVI), tumor localization within the rectum (low, medium, high rectum, 
recto-sigmoid junction). Computer tomography was performed in all patients for distant metastases 
assessment. Results: Out of 15 patients, 12 (66.7%) were male, and 3 (33.3 %) were female, with a mean 
age of 65 years (range 50 to 80years). Six cases had middle rectum localization, 6 cases in low rectum, 
and 3 patients had recto-sigmoid localization. At initial MRI, 7 cases (46.6%) had MR signs for T3 stage, 
and 8 cases (53.3%) had T4 stage. Comparison of MRI results before and after chemoradiotherapy 
showed stage decreasing in 5(33.3%), from T4 to T3 stage. In 11 patients (73.7%), EMVI after therapy 
became negative with a statistically significant difference before and after chemoradiotherapy. 
All patients before therapy had different numbers of metastatic lymph nodes in mesorectum, with 
number reduction in all cases after therapy and two patients were without metastatic lymph nodes. 
Conclusion: MRI has a significant value in pre- and post-neoadjuvant therapy assessment of resection 
margins involved by tumor, positive extramural vascular invasion, and metastatic lymph node around 
resection margins. This is important for operative planning in order to avoid extensive resection with 
surgery techniques that preserve the anal sphincter. 
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Introduction
Rectal cancer is the third most com-
mon malignant disease worldwide af-
ter prostate cancer and lung cancer 
in men, and breast and lung cancer 
in the female population in the devel-
oped countries1.
Preoperative staging of rectal can-
cer with magnetic resonance imag-
ing (MRI) is very important for the 
decision in further treatment of the 
disease, whether it would be chemo-
radiotherapy alone (neoadjuvant) 
or simple surgical treatment. This 
is aimed at achieving reduced re-
currence rate and increasing of the 
5-year survival rate2,3.
Preoperative chemoradiotherapy is 
very important because it can reduce 
the stage of advanced rectal cancer 
in some patients with good answer 
to the therapy. Also, the neoadjuvant 
therapy is used to minimize the risk 
of distant metastases, and if possible 
to perform less extensive surgical 
techniques. If the tumor is localized 
in low rectum, it is very important to 
use sphincter preservation technique 
instead of permanent colostomy4, 5. 
The multimodal approach includes 
a short cycle of radiotherapy, com-
bined with chemotherapy. The key 
point is whether patients are candi-
dates only for surgical treatment or 
chemoradiotherapy before the surgi-
cal treatment6. Besides other radiol-
ogy diagnostic modalities, MRI is the 
best choice for rectal cancer stag-
ing, offering multiplanar projection, 
great resolution and good soft tissue 
contrast7,8. MRI is also performed af-
ter chemoradiotherapy, before defin-
itive surgery, to enable its planning, 
with restaging due to the expected 
reduction of the stage and size of the 
tumor after the neoadjuvant treat-
ment9,10.
The aim of this study was to evalu-
ate chemoradiotherapy effects in 
advanced stage rectal carcinoma by 
comparison of MRI findings before 
and after chemoradiotherapy.
  
Material and methods
Prospectively were evaluated pelvic 
MRIs in 15 patients with an advanced 
stage of rectal cancer proven at colo-
noscopy with age range from 50 to 80 
years, and an average age of 65 ± 10.2 
years.
Inclusion criteria were: patients with 
proven rectal cancer by colonoscopy 
in whom pre-operative staging with 
MRI was indicated. Patients with 
metal implant or with claustropho-
bia were excluded.
In all patients a preoperative MRI stag-
ing was performed in order to deter-
mine tumor (T) and nodal (N) stage, 
presence of extra-mural vascular in-
vasion (EMVI), with assessment of the 
level of tumor localization within the 
rectum (low, medium, high rectum, 
and recto-sigmoid junction). Computer 
tomography (CT) was performed in all 
patients to assess presence of distant 
metastases. The pelvic MRI was done 
on 1.5 T machine, with the standard 
protocol: sagittal T2WI, axial T1 WI, 
T2 WI and DWI. Initial MRI was with-
out contrast media. After neoadjuvant 
treatment, pelvic MRI and restaging 
was done with intravenous adminis-
tration of gadolinium in order to assess 
the effects of chemoradiotherapy.
According to the level of tumor lo-
calization, it was divided into three 
groups: within low rectum when its 
localization was up to 5 cm from the 
anorectal junction, in the mid-rec-
tum from 5 to 10 cm from the ano-
rectal junction, and 10 cm above the 
anorectal junction was a high rectal 
localization of the tumor.
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T3 stage is when the tumor pene-
trates the rectal wall and grows into 
the mesorectal adipose tissue. If the 
tumor is less than 2 mm from the 
mesorectal fascia nearby or is infil-
trated, then it is a potential seizure 
that requires preoperative neoadju-
vant treatment. T4 stage is when the 
tumor grows in neighboring organs 
or they are infiltrated by the tumor 
(vagina, uterus in women, prostate in 
men as well as in muscular and pelvic 
organs). If the tumor infiltrates the 
vagina or the prostate the organ loses 
its normal morphology and structure 
locally, then, fat line between tumor 
and the organ cannot be visualized 
and the infiltrated part of the organ 
becomes with heterogenic signal in-
tensity and has the same character-
istics like the tumor itself witch is in 
continuity.12
Local nodal staging determines the 
number of MRI suspected positive 
lymph nodes. Although metastatic 
altered LNs are larger than benign 
ones, metastatic deposits (MS) may 
also be present in small LNs. Most of-
ten the size of LN with MS-deposits is 
5 - 8 mm, with irregular contours and 
mixed signal intensity. When evalu-
ating mesorectal nodules, the dis-
tance to the mesorectal fascia should 
be taken into account. Distance less 
than 2 mm is a sign for local recid-
ive.20
Extramural vascular invasion (EMVI) 
is accounted as positive on MRI 
when the small blood vessels within 
mesorectum and under muscularis 
propria, are thickened, with irregu-
lar contours, and with heterosignal 
intensity with large size and diam-
eter which makes it visible for MRI 
detection. This is a MR sign of exis-
tence of MS deposits in intramural 
blood vessels. It is best visualized at 
axial T2WI and DWI. After neoadju-
vant treatment there are changes in 
the presentation of EMVI. This effect 
was visualized by MRI signs of forma-
tion a fibrosis, which has hyposignal 
characteristics on T1WI and T2 WI, 
has flat margins and is  at the places 
of previous with metastatic embolus 
changed EMVI.
The obtained data were analyzed 
with the statistical computer pro-
gram SPSS 23.0 for Windows.
Results
Out of 15 patients, 12 (66.7%) were 
male, and 3 (33.3%)were female, with 
a mean age of 65 ± 10.2 years (age 
range 50 to 80 years). Rectal cancer 
was localized in the middle rectum in 
6 cases, as well as in the low rectum, 
Figure 1.  Localization of rectal cancer
rectosigma                middle rectum                low rectum
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and in 3 patients the recto sigmoid 
part was affected by the malignant 
process.
Five (33.3%) had metastatic deposits 
at the initial MRI examination. Four 
of them (80%) had liver metastases, 
and one patient had both liver and 
lung metastases.
At initial MRI, 7 cases (46.6%) had MR 
signs for T3 stage of rectal cancer, 
and in 8 cases (53.3%) the stage of rec-
tal cancer was T4.
Comparison of MRI results before 
and after chemo radiotherapy treat-
ment showed that in 5 patients there 
was a change in the findings in rela-
tion to T-staging. Of the 15 patients, 
in 5 patients (33.3%) T stage decreased 
from T4 to T3 stage. In the remain-
ing 10 patients (66.67%) there were no 
changes in the T stage.
In 11 patients (73.7 %), the change in 
EMVI status was seen after MR ther-
apy (Table 1). All 11 patients who had 
positive EMVI, after therapy became 
EMVI negative. The other 4 patients 
had still positive EMVI. Statistically 
significant was the difference in EMVI 
status determined by MR, before and 
after chemoradiotherapy (p = 0.0026).
EMVI status /changes n (%)
no 4 (26.67)
yes 11 (73.33)
Table 1.  EMVI status before /after therapy  
Table 2.  Number of LNs before and after therapy
Number 
of lymph 
nodes per 
patent
Before therapy
n (%)
After therapy
n (%)
p = level
0 2 (13.33) p=0.00065 sig
1 7 (46.67)
2 1 (6.67) 5 (33.33)
3 5 (33.33) 1 (6.67)
4 5 (33.33)
5 3 (20)
7 1 (6.67)
Wilcoxon Matched Pairs Test = 3.4 p=0.000655
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All patients before therapy had meta-
static lymph nodes in the mesorec-
tum, and after therapy the number 
was reduced in all patients, and two 
patients (13.3%) had no metastatic 
lymph nodes (Table 2).  
The patient, who had 2 MS changed 
LNs on MR before therapy, after ther-
apy was negative.
Of five patients, who had 3 MS 
changed LNs before therapy, one had 
no MS LNs and 4 had only one MS LN 
after therapy. Of five patients, who 
had 4 MS LNs before therapy, 3 pa-
tients had only one MS LN, and 2 pa-
tients had only 2 MS LNs after thera-
py. Of three patients, who had 5 MS 
LNs before therapy, 3 patients had 
2 MS LNs after therapy. One patient 
who had 7 MS LNs before therapy, 
had only 3 metastatic changed LNs 
after therapy. 
Discussion
The preoperative chemoradiotherapy 
or neoadjuvant treatment increases 
the 5-year survival rate while achiev-
ing negative circulatory resection 
margins. It can also provide sphinc-
ter-saving techniques in patients 
with low rectal tumors by reducing 
the stage of the locally advanced tu-
mor process.
Post-chemoradiotherapy MRI restag-
ing is performed in order to determine 
the condition after the neoadjuvant 
treatment, which would also affect 
the choice of surgical technique18.
Rectal cancer restaging is a compari-
son of all MR parameters before and 
after neoadjuvant treatment by using 
the same MRI protocol19.
Initial MRI was without contrast 
media administration due to partial 
volume effect given by the contrast 
medium that can interpret the more 
advanced stages of rectal cancer at 
the primary MRI staging before neo-
adjuvant treatment. After neoadju-
vant treatment, pelvic MRI and re-
staging was done with intravenous 
administration of gadolinium, in or-
der to assess the effects of chemo-
radiotherapy: desmoplastic reaction 
which has to be differentiated from 
viable tumor, and changes in the ex-
tramural vascular invasion (EMVI). 
Also, administration of contrast me-
dium provides better insight into the 
metastatic changes of lymph nodes.
When it comes to changes of T4 to T3 
stages at MRI contrast administration 
gives adequate view of the fibrotic 
changes where viable tumor was first 
present, showing chemoradiotherapy 
effects, with decreasing of the tumor 
size which leads to down-stage of the 
rectal carcinoma12.
The anatomical localization of the 
rectum, its fixation on the pelvic floor 
and fat tissue, as well as the absence 
of peristalsis, which avoids moving 
artifacts, makes it an ideal organ 
for recording with the MRI imaging 
method.  
Candidates for preoperative neoad-
juvant treatment are patients in ad-
vanced stage (T3b and T4 stage) dis-
ease, patients with involved resection 
margins, patients in stage T3 and T4 
with positive LNs, and positive extra-
mural vascular induction, also tu-
mors localized in a low rectum where 
a reduction of extensibility of the pro-
cess is required in order to approach 
sphincter preservation techniques5.
In our study, a comparison of MRI 
results before and after chemora-
diotherapy treatment showed that 
in 33.3% of the cases there were MRI 
signs of change from T4 to T3 stage. 
Change of EMVI status after therapy 
was found in 73.3% of the cases. Prior 
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to neoadjuvant treatment, the MRI 
finding in all patients presented with 
positive lymphatic status. After the 
therapy, the MRI finding showed a 
significant regression of metastatic 
lymph nodes. 
All patients before therapy had meta-
static lymph nodes in the mesorec-
tum, and after therapy the number 
was reduced in all patients and two 
patients (13.3%) had no metastatic 
lymph nodes (Table 2).
EMVI is an independent prognostic 
indicator in the treatment of rectal 
cancer, but has recently been taken 
as an important indicator in mak-
ing the decision to start neoadjuvant 
treatment13,16.
Positive EMVI affects the increase in 
the number of postoperative relapses 
and is therefore taken into account 
when deciding to start preoperative 
neoadjuvant treatment17. 
In this study, 73.7 % of the cases showed 
statistically significant changes in 
EMVI status after MR therapy from 
positive to negative EMVI. 
Although this group of 15 patients is 
small for more significant statistical 
analysis, it is a sufficient indicator of 
the direction in the treatment of rec-
tal cancer. It confirms the importance 
of multimodal treatment of rectal 
cancer, especially in reducing tumor 
size, allowing for negative resection 
margins, reducing nodal status, and 
altering the positive extramural vas-
cular invasion.
Opportunities are opened for its 
greater application in the future, 
bringing it closer to world standards 
in that field in order to improve the 
overall treatment of rectal cancer, 
which would increase the 5-year sur-
vival rate, reduce recurrence rate or 
overall benefit of the patient in the 
struggle and victory of the disease.
Conclusion
Magnetic resonance imaging has a 
significant value in evaluating of all 
T4 stages of rectal cancers and T3 
stages in which  resection margins 
are involved by the tumor, tumors in 
which there is a finding of a positive 
extramural vascular invasion, and 
malignant lymph node around the 
resection margin. This is very impor-
tant in making decision for preopera-
tive chemoradiotherapy, as well as in 
the assessment of the post-neoadju-
vant treatment. In the case of tumor 
growth near the mesorectal fascia, 
this would mean less extensive resec-
tion and application of surgical tech-
niques to preserve the anal sphincter. 
This is especially important for sur-
geons to prevent the development of 
permanent colostomy, which will sig-
nificantly improve the patient quality 
of life.
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